{"url": "/factchecks/2019/jul/26/amy-klobuchar/klobuchar-says-there-are-enough-drug-lobbyists-dc-/", "speaker": "Amy Klobuchar", "vclaim": "\"There are, literally, two pharmaceutical pressure groups per congressman.\"", "truth_label": "mostly-true", "date": "stated on July 15, 2019 in comments made at an AARP-sponsored Democratic presidential primary candidate forum:", "title": "Klobochar says there are enough drug pressure groups in the capital to double the law enforcement team.", "text": "The elderly citizens are very interested in the prices of medicines and the future of medical care, so it was not surprising that the first question put to X at the Association's Presidential Candidates Forum in Iowa on July 15. Amy Klobochar was dealing with these subjects. As President Klopchar said, it will unleash the bargaining power of Medicare to lower the prices of drugs. However, she pointed out what she would face: \"There are literally two pharmacological pressure groups per congressman. They think they own Congress. They don't own me.\" The suspension of the Minnesota Democratic Party has given rise to continuing concern about the political power of drug manufacturers in the ongoing debate on the prices of medicines in the United States, the highest price in the world for products with a trade name. The Congress and the President say they want to reduce them, but so far there have been few actions or results that can be proved. We decided to take a look: are legislators in Washington outnumbered by pharmacists? We called the Klobochar campaign to find out the basis for her statement. They soon sent information from Oben-Seritz, a website tracking the number of pressure groups and spending on pressure, and promised to return to contact to confirm that the site was the source of the senator. We don't hear anymore. According to the figures still, the information of the Oben Srits has become our starting point. Their statements come from the quarterly reports submitted by members of pressure groups, pressure companies and organizations to the Secretary of the Senate. The pressure groups must register with the secretary &apos; s office if they pay her to exert pressure on behalf of the client, make more than one contact with government officials in relation to the client &apos; s cases, and spend at least 20 per cent of their time in lobbying and related activities. In 2018, the number of members of pharmaceutical/health pressure groups was 1,451, the last full year of available data. This category goes beyond mere prescriptions to include pressure groups for medical equipment manufacturers and extraordinary health product producers. Using a narrower definition that covers only pressure groups representing pharmaceutical manufacturing interests, the group has 828 members. And then we did the math. There are 535 members of Congress; 100 senators and 435 members of the House of Representatives. It was found that Klobochar was either too much or too little, depending on the extent of a single definition of the pharmaceutical industry. There are 2.7 pressure groups per congressman if one looks at the larger pharmaceutical/health product industry, but only 1.5 per member when considering the drug industry only. Stephen Knivel said, \"It's a lot in both directions,\" a public citizen's access lawyer. On January 14, 2021, Chuck Grasley stated in a tweet that insulin prices had \"lost the RoOOF for patients/taxpayers bc from the manufacturer, a health plan and PBM Biz practices.\" By Madison Black \u2022 February 2, 2012, how do these lists gather against other industries? The number of pressure groups on medicines/health products was 1,451 persons higher than the number of pressure groups in all other 89 categories, according to an analysis by Daniel Obel, a senior researcher at OpenSecrets. The electronics and equipment industry ranked second, with 1,121 lobbyists last year. Education was a third, reaching 1,027. Both women &apos; s activists and abortion rights activists or opponents were in the latter position - with eight persons each. The number of pressure groups in industry exceeds the number of consumer pressure groups throughout the board, and the experts said. This means that members of Congress and their employees \"hear again and again from industry because they have pressure groups more than anyone else,\" said Lee Drutman, a senior colleague at the New America think tank and author of America's work in pressure. Many of those pressure groups were more experienced than the young staff they met. When legislators and employees hear much more than one side of the matter, it can lead to \"a distorted picture of how regulations can work or affect public health,\" as Drutman said. Neville agreed to it. When he went to Capitol Hill to talk to legislators, they generally heard more from industry than \"people trying to lower health costs,\" he said. \"The existence of resources and the human power to do so makes them enormous and influential.\" The second part of the Clobochar statement - that the pressure groups on their \"congress\" drug companies - puts forward another element of this issue: in Washington, the money and the pressure go hand in hand. The drug industry certainly has one of the largest war funds to spend on pressure. In the past year, total expenditure by drug groups and health providers, which includes manufacturers of medical devices and other health-related materials, amounted to $283 million, according to OpenSecrets. The amount spent by drug manufacturers alone is huge: it amounted to $169 million last year. This has been the most frequent since 2009, in the midst of the debate on the law on affordable care. Finalized in second place, insurance industry, spent $158 million. So what does the drug industry put pressure on? Their recent concerns revolve around the prices of medicines. Whenever the Council sees a threat or opportunity - as it did when Congress discussed the Anti-Narcotics Act in 2009, or now, with the candidates, the President and Congress have all focused on the rising prices of prescription drugs - industry is increasing spending. \"Companies respond to a certain degree to the political environment,\" said Druttman. Of course, the drug industry directs millions of dollars in direct campaign contributions to members of Congress each year. \"There are, literally, two pharmaceutical pressure groups per congressman.\" We found that there are more than twice as many members of each congressman &apos; s pharmacist pressure groups if we look at the broader category of health product representatives, but only 1.5 per member if the comparison is limited to those who exert pressure on pharmaceutical companies. We're mostly assessing her statement as correct.", "vclaim_id": "vclaim-pol-00388"}